Osteoporosis in men

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 25, Issue 2, 2011, Pages 321-335

  Gielen, Evelien ^a   Vanderschueren, Dirk ^a   Callewaert, Filip ^a   Boonen, Steven ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

ageing; bisphosphonates; bone mineral density; dual energy X ray absorptiometry; fractures; male; osteoporosis; sarcopenia; teriparatide

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; ESTROGEN; GLUCOCORTICOID; PARATHYROID HORMONE[1-34]; PLACEBO; RALOXIFENE; RISEDRONIC ACID; SELECTIVE ANDROGEN RECEPTOR MODULATOR; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SEX HORMONE; TESTOSTERONE; ZOLEDRONIC ACID;

AGING; ALCOHOL CONSUMPTION; BONE DENSITY; CLINICAL ASSESSMENT; DIABETES MELLITUS; FRACTURE; FRAGILITY FRACTURE; HIP FRACTURE; HUMAN; HYPOGONADISM; IDIOPATHIC HYPERCALCIURIA; IDIOPATHIC OSTEOPOROSIS; INCIDENCE; LABORATORY TEST; MORBIDITY; MORTALITY; OSTEOPOROSIS; PATHOPHYSIOLOGY; PROSTATE CARCINOMA; REVIEW; RISK ASSESSMENT; SCORING SYSTEM; SECONDARY OSTEOPOROSIS; SMOKING; VERTEBRA FRACTURE;

ABSORPTIOMETRY, PHOTON; AGED; ALCOHOLISM; BONE DENSITY; DIABETES MELLITUS, TYPE 1; DIPHOSPHONATES; HIP FRACTURES; HUMANS; HYPERCALCIURIA; MALE; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES; SMOKING; SPINAL FRACTURES; TERIPARATIDE;

EID: 79952560131     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beem.2010.08.012     Document Type: Review

References (101)

1. Parfitt AM. The cellular basis of bone remodeling: the quantum concept reexamined in light of recent advances in the cell biology of bone. Calcified Tissue International 1984; 36: S37-S45. (Pubitemid 14043313)
2. National Osteoporosis Foundation. Clinician's guide to prevention and treatment of osteoporosis. Washington, DC: National Osteoporosis Foundation, 2010.
3. Van Staa TP, Dennison EM, Leufkens HG et al. Epidemiology of fractures in England and Wales. Bone 2001; 29: 517-522. (Pubitemid 33124293)
4. Donaldson LJ, Reckless IP, Scholes S et al. The epidemiology of fractures in England. Journal of Epidemiology and Community Health 2008; 62: 174-180. (Pubitemid 351196859)
5. Jones G, Nguyen T & Sambrook PN. Symptomatic fracture incidence in elderly men and women: the Dubbo osteoporosis epidemiology study (DOES). Osteoporosis International 1994; 4: 277-282. (Pubitemid 24291436)
6. Johell O & Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporosis International 2006; 17: 1726-1733. (Pubitemid 44607392)
7. Melton 3rd LJ, Chrischilles EA, Cooper C et al. How many women have osteoporosis? Journal of Bone and Mineral Research 1992; 7: 1005-1010.
8. Center JR, Nguyen TV, Schneider D et al. Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet 1999; 353: 878-882. (Pubitemid 29126875)
9. Cooper C, Campion G & Melton 3rd LJ. Hip fractures in the elderly: a word-wide projection. Osteoporosis International 1992; 2: 285-289.
10. Schwartz AV, Kelsey JL, Maggi S et al. International variation in the incidence of hip fractures: cross-national project on osteoporosis for the World Health Organization Program for Research on aging. Osteoporosis International 1999; 9: 242-253.
11. Maggi S, Kelsey JL, Litvak J et al. Incidence of hip fractures in the elderly: a cross-national analysis. Osteoporosis International 1991; 1: 232-241.
12. Poór G, Atkinson EJ, O'Fallon WM et al. Determinants of reduced survival following hip fractures in men. Clinical Orthopaedics and Related Research 1995; 319: 260-265.
13. Huuskonen J, Kröger H, Arnala I et al. Characteristics of male hip fracture patients. Annales Chirurgiae et Gynaecologiae 1999; 88: 48-53. (Pubitemid 29205295)
14. Diamond TH, Thornley SW, Sekel R et al. Hip fracture in elderly men: prognostic factors and outcomes. Medical Journal of Australia 1997; 167: 412-415. (Pubitemid 27474867)
15. Cree M, Soskolne CL, Belseck E et al. Mortality and institutionalization following hip fracture. Journal of the American Geriatrics Society 2000; 48: 283-288. (Pubitemid 30164211)
16. Haentjens P, Magaziner J, Colón-Emeric CS et al. Meta-analysis: excess mortality after hip fracture among older women and men. Annals of Internal Medicine 2010; 152: 380-390.
17. Kannegaard PN, van der Mark S, Eiken P et al. Excess mortality in men compared with women following a hip fracture. National analysis of comedications, comorbidity and survival. Age and Ageing 2010; 39: 203-209.
18. Schürch MA, Rizzoli R, Mermillod B et al. A prospective study on socioeconomic aspects of fracture of the proximal femur. Journal of Bone and Mineral Research 1996; 11: 1935-1942. (Pubitemid 26425687)
19. Cooper C, Atkinsson EJ, O'Fallon WM et al. Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989. Journal of Bone and Mineral Research 1992; 7: 221-227.
20. O'Neill TW, Felsenberg D, Barlow J et al. The prevalence of vertebral deformity in European men and women: the European vertebral osteoporosis study. Journal of Bone and Mineral Research 1996; 11: 1010-1018. (Pubitemid 26200053)
21. Felsenberg D, Sülman AJ, Lunt M et al. Incidence of vertebral fractures in Europe: results from the European prospective osteoporosis study (EPOS). Journal of Bone and Mineral Research 2002; 17: 716-724. (Pubitemid 34246648)
22. Adachi JD, Ioannidis G, berger C et al. The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada. Osteoporosis International 2001; 12: 903-908.
23. Metlton 3rd LJ. Epidemiology of spinal osteoporosis. Spine 1997; 22: 2S-11S.
24. Center JR, Bliuc D, Nguyen TV et al. Risk of subsequent fracture after low-trauma fracture in men and women. Journal of the American Medical Association 2007; 297: 387-394. (Pubitemid 46155800)
25. Hasserius R, Karlsson MK, Nilson BE et al. Prevalent vertebral deformities predict increased mortality and increased fracture rate in both men and women: a 10-year population-based study of 598 individuals from the Swedish cohort in the European Vertebral Osteoporosis Study. Osteoporosis International 2003; 14: 61-68. (Pubitemid 36267902)
26. Haentjens P, Johnell O, Kanis JA et al. Evidence from data searches and life-table analyses for gender-related differences in absolute risk of hip fracture after Colles' or spine fracture: Colles' fracture as an early and sensitive marker of skeletal fragility in white men. Journal of Bone and Mineral Research 2004; 19: 1933-1944. (Pubitemid 41103407)
27. Cuddihy MT, Gabriel SE, Cowson CS et al. Forearm fractures as predictors of subsequent osteoporotic fractures. Osteoporosis International 1999; 9: 91-97.
28. Kanis JA, Melton 3rd LJ, Christiansen C et al. The diagnosis of osteoporosis. Journal of Bone and Mineral Research 1994; 9: 1137-1141. (Pubitemid 24985932)
29. Looker AC, Orwoll ES, Johnston Jr. CC et al. Prevalence of low femoral bone density in older US adults from NHANES III. Journal of Bone and Mineral Research 1997; 12: 1761-1768. (Pubitemid 27500187)
30. Bailey DA, Martin AD, McKay HA et al. Calcium accretion in girls and boys during puberty: a longitudinal analysis. Journal of Bone and Mineral Research 2000; 15: 2245-2250.
31. Seeman E. Sexual dimorphism in skeletal size, density, and strength. Journal of Clinical Endocrinology and Metabolism 2001; 86: 4576-4584. (Pubitemid 33020488)
32. Riggs BL, Melton 3rd LJ, Robb RA et al. Population-based study of age and sex differences in bone volumetric density, size, geometry, and structure at different skeletal sites. Journal of Bone and Mineral Research 2004; 19: 1945-1954. (Pubitemid 41103408)
33. Kirmani S, Christen D, van Lenthe GH et al. Bone structure at the distal radius during adolescent growth. Journal of Bone and Mineral Research 2009; 24: 1033-1042.
34. Lu PW, Cowell CT, Lloyd-Jones SA et al. Volumetric bone mineral density in normal subjects, aged 5-27 years. Journal of Clinical Endocrinology and Metabolism 1994; 81: 1586-1590.
35. Silva MJ & Gibson LJ. Modeling the mechanical behavior of vertebral trabecular bone: effects of age-related changes in microstructure. Bone 1997; 21: 191-199. (Pubitemid 27395407)
36. Seeman E. Pathogenesis of bone fragility in women and men. Lancet 2002; 359: 1841-1850. (Pubitemid 34607063)
37. Daniell HW. Osteoporosis after orchiectomy for prostate cancer. Journal of Urology 1997; 157: 439-444. (Pubitemid 27026812)
38. Smith EP, Boyd J, Frank GR et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. New England Journal of Medicine 1994; 331: 1056-1061. (Pubitemid 24317698)
39. Morishima A, Grumbach MM, Simpson ER et al. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. Journal of Clinical Endocrinology and Metabolism 1995; 80: 3689-3698.
40. Bilezikian JP, Morishima A, Bell J et al. Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency. New England Journal of Medicine 1998; 339: 599-603. (Pubitemid 28385657)
41. Vandenput L & Ohlsson C. Estrogens as regulators of bone health in men. Nature reviews. Endocrinology 2009; 5: 437-443.
42. Vanderschueren D, Pye SR, Venken K et al. Gonadal sex steroid status and bone health in middle-aged and elderly European men. Osteoporosis International 2010; 21: 1331-1339.
43. Leder BZ, LeBlanc KM, Schoenfeld et al. Differential effects of androgens and estrogens on bone turnover in normal men. Journal of Clinical Endocrinology and Metabolism 2003; 88: 204-210. (Pubitemid 36115166)
44. Callewaert F, Boonen S & Vanderschueren D. Sex steroids and the male skeleton: a tale of two hormones. Trends in Endocrinology and Metabolism 2010; 21: 89-95.
45. Legrand E, Hedde C & Gallois Y. Osteoporosis in men: a potential role for the sex hormone binding globuline. Bone 2001; 29: 90-95. (Pubitemid 32717087)
46. LeBlanc ES, Nielson CM, Marshall LM et al. The effects of serum testosterone, estradiol, and sex hormone binding globuline levels on fracture risk in older men. Journal of Clinical Endocrinology and Metabolism 2009; 94: 3337-3346.
47. Kelepouris N, Harper KD, Gannon F et al. Severe osteoporosis in men. Annals of Internal Medicine 1995; 123: 452-460.
48. Reid IR. Glucocorticoid osteoporosis - mechanisms andmanagement. European Journal of Endocrinology 1997; 137: 209-217.
49. Van Staa TP, Leufkens HG & Cooper C. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporosis International 2002; 13: 777-787. (Pubitemid 36336722)
50. Cawthon PM, Harrison SL, Barrett-Connor E et al. Alcohol intake and its relationship with bone mineral density, falls, and fracture risk in older men. Journal of the American Geriatrics Society 2006; 54: 1649-1657. (Pubitemid 44665202)
51. Tucker KL, Jugdaohsingh R, Powell JJ et al. Effects of beer, wine and liquor intakes on bone mineral density in men and premenopausal women of the Framingham Offspring cohort. Journal of Bone and Mineral Research 2004; 19: 297-307. (Pubitemid 38116744)
52. Kanis JA, Johansson H, Johnell O et al. Alcohol intake as a risk factor for fracture. Osteoporosis International 2005; 16: 737-742. (Pubitemid 40933589)
53. Khosla S, Lufkin EG, Hodgson SF et al. Epidemiology and clinical features of osteoporosis in young individuals. Bone 1994; 15: 551-555. (Pubitemid 24249214)
54. Zerwekh JE, Sakhaee K, Breslau NA et al. Impaired bone formation in male idiopathic osteoporosis: further reduction in the presence of concomitant hypercalciuria. Osteoporosis International 1992; 2: 128-134.
55. Szulc P, Garnero P, Claustrat B et al. Increased bone resorption in moderate smokers with low body weight: the Minos study. Journal of Clinical Endocrinology and Metabolism 2002; 87: 666-674. (Pubitemid 34158235)
56. Epstein S & Leroith D. Diabetes and fragility fractures - a burgeoning epidemic? Bone 2008; 43: 3-6.
57. Saller A, Maggi S, Romanato G et al. Diabetes and osteoporosis. Aging Clinical and Experimental Research 2008; 20: 280-289.
58. Reed BY, Zerwekh JE, Sakhaee K et al. Serum IGF 1 is low and correlated with osteoblastic surface in idiopathic osteoporosis. Journal of Bone and Mineral Research 1995; 10: 1218-1224.
59. Riggs BL, Khosla S & Melton 3rd LJ. Sex steroids and the construction and conservation of the adult skeleton. Endocrine Reviews 2002; 23: 279-302. (Pubitemid 34651948)
60. Vanderschueren D, Van Herck E, Nijs J et al. Aromatase inhibition impairs skeletal modeling and decreases bone mineral density in growing male rats. Endocrinology 1997; 138: 2301-2307. (Pubitemid 27215229)
61. Callewaert F, Venken J, Ophoff J et al. Differential regulation of bone and body composition in male mice with combined inactivation of androgen and estrogen receptor-a. FASEB Journal 2009; 23: 232-240.
62. Boonen S, Vanderschueren D, Geusens P et al. Age-associated endocrine deficiencies as potential determinants of femoral neck (type II) osteoporotic fracture occurrence in elderly men. International Journal of Andrology 1997; 20: 134-143. (Pubitemid 27470084)
63. Bischoff HA, Borchers M, Gudat F et al. In situ detection of 1,25-dihydroxyvitamin D3 receptor in human skeletal muscle tissue. Histochemical Journal 2001; 33: 19-24.
64. Bischoff-Ferrari HA, Borchers M, Gudat F et al. Vitamin D receptor expression in human muscle tissue decreases with age. Journal of Bone and Mineral Research 2004; 19: 265-269. (Pubitemid 38116740)
65. Gerdhem P, Ringsberg KA, Obrant KJ et al. Association between 25-hydroxy vitamin D levels, physical activity, muscle strength and fractures in the prospective population-based OPRA study of elderly women. Osteoporosis International 2005; 16: 1425-1431. (Pubitemid 41534648)
66. Pernow Y, Granberg B, Sääf M et al. Osteoblast dysfunction in male idiopathic osteoporosis. Calcified Tissue International 2006; 78: 90-97. (Pubitemid 43228088)
67. Pernow Y, Hauge EM, Linder K et al. Bone histomorphometry in male idiopathic osteoporosis. Calcified Tissue International 2009; 84: 430-438.
68. Ferrari SL, Deutsch S, Baudoin C et al. LRP5 gene polymorphisms and idiopathic osteoporosis in men. Bone 2005; 37: 770-775. (Pubitemid 41773486)
69. Kurland ES, Rosen CJ, Cosman F et al. Insulin-like growth factor-1 in men with idiopathic osteoporosis. Journal of Clinical Endocrinology and Metabolism 1997; 82: 2799-2805. (Pubitemid 27385627)
70. Peris P, Martínez-Ferrer A, Monegal A et al. Aetiology and clinical characteristics of male osteoporosis. Have they changed in the last few years? Clinical and Experimental Rheumatology 2008; 26: 582-588.
71. Gennari L & Brandi L. Genetics of male osteoporosis. Calcified Tissue International 2001; 69: 200-201.
72. Patsch J, Muschitz C, Resch H et al. Of mice and men: pathophysiology of male osteoporosis. Journal of Men's Health 2007; 4: 87-93. (Pubitemid 46367811)
73. Szulc P, Kaufman JM & Delmas PD. Biochemical assessment of bone turnover and bone fragility in men. Osteoporosis International 2007; 18: 1451-1461. (Pubitemid 47512683)
74. Kamel HK. Male osteoporosis: new trends in diagnosis and therapy. Drugs and Aging 2005; 22: 741-748.
75. Orwoll E. Assessing bone density in men. Journal of Bone and Mineral Research 2000; 15: 867-1870.
76. Baim S, Binkley N, Bilezikian et al. Official positions of the international society for clinical densitometry and executive summary of the 2007 ISCD position development conference. Journal of Clinical Densitometry 2008; 11: 75-91.
77. Writing Group for the ISCD Position Development Conference. Diagnosis of osteoporosis in men, premenopausal women, and children. Journal of Clinical Densitometry 2004; 7: 17-26.
78. Liu G, Peacock M, Eilam O et al. Effect of osteoarthritis in the lumbar spine and hip on bone mineral density and diagnosis of osteoporosis in elderly men and women. Osteoporosis International 1997; 7: 564-569. (Pubitemid 28009018)
79. Vallarta-Ast N, Krueger D & Binkley N. An evaluation of forearm BMD measurement for diagnosis and treatment monitoring in men. Journal of Bone and Mineral Research 2007; 22(Suppl. 1): S300.
80. Schuit SCE, Van der Klift M, Weel AEAM et al. Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam study. Bone 2004; 34: 195-202. (Pubitemid 38142449)
81. Thomson-John M, Codd MB, Manne S et al. Risk factors for the development of osteoporosis and osteoporotic fractures among older men. Journal of Rheumatology 2009; 36: 1947-1952.
82. Melton 3rd LJ, Atkinson EJ, Cooper C et al. Vertebral fractures predict subsequent fractures. Osteoporosis International 1999; 10: 214-221. (Pubitemid 29458716)
83. Kanis JA, Johnell O, Oden A et al. FRAX™ and the assessment of fracture probability in men and women from the UK. Osteoporosis International 2008; 19: 385-397.
84. Tang BM, Eslick GD, Nowson C et al. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 2007; 25(370): 657-666. (Pubitemid 47285316)
85. Orwoll E, Ettinger M, Weiss S et al. Alendronate for the treatment of osteoporosis in men. New England Journal of Medicine 2000; 343: 604-610. (Pubitemid 30659471)
86. Boonen S, Orwoll ES, Wenderoth D et al. Once-weekly risedronate in men with osteoporosis: results of a 2-year, placebo-controlled, double-blind, multicenter study. Journal of Bone and Mineral Research 2009; 24: 719-725.
87. Ringe JD, Faber H, Farahmand P et al. Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study. Rheumatology International 2006; 26: 427-431.
88. Ringe JD, Farahmand P, Faber H et al. Sustained efficacy of risedronate in men with primary and secondary osteoporosis: results of a 2-year study. Rheumatology International 2009; 29: 311-315.
89. Lyles KW, Colon-Emeric C, Magaziner J et al. Zoledronic acid and clinical fractures and mortality after hip fracture. New England Journal of Medicine 2007; 357: 1799-1809. (Pubitemid 350044800)
90. Orwoll E, Scheele W, Paul S et al. The effect of tiraparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis. Journal of Bone and Mineral Research 2003; 18: 9-17. (Pubitemid 36008334)
91. Lagdahl BL, Marin F, Shane E et al. Teriparatide versus alendronate for treating glucorticoid-induced osteoporosis: an analysis by gender and menopausal status. Osteoporosis International 2009; 20: 2095-2104.
92. Kaufman JM, Orwoll E, Goemaere S et al. Teriparatide effects on vertebral fractures and bone mineral density in men with osteoporosis: treatment and discontinuation of therapy. Osteoporosis International 2005; 16: 510-516.
93. Finkelstein JS, Leder BZ, Burnett SAM et al. Effects of teriparatide, alendronate, or both on bone turnover in osteoporotic men. Journal of Clinical Endocrinology and Metabolism 2006; 91: 2882-2887. (Pubitemid 44271730)
94. Snyder PJ, Peachy H, Berlin JA et al. Effects of testosterone replacement in hypogonadal men. Journal of Clinical Endocrinology and Metabolism 2000; 85: 2670-2677. (Pubitemid 32269134)
95. Snyder PJ, Peachey H, Hannoush P et al. Effect of testosterone treatment on bone mineral density in men over 65 years of age. Journal of Clinical Endocrinology and Metabolism 1999; 84: 1966-1972. (Pubitemid 30647018)
96. Anderson FH, Francis RM, Peaston RT et al. Androgen supplementation in eugonadal men with osteoporosis: effects of six months treatment on markers of bone formation and resorption. Journal of Bone and Mineral Research 1997; 12: 472-478. (Pubitemid 27120485)
97. Wald M, Meacham RB, Ross LS et al. Testosterone replacement therapy for older men. Journal of Andrology 2006; 27: 126-132.
98. Smith MR, Fallon MA, Lee H et al. Raloxifene to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer: a randomized controlled trial. Journal of Clinical Endocrinology and Metabolism 2004; 89: 3841-3846. (Pubitemid 39071482)
99. Uebelhart B, Herrmann F, Pavo I et al. Raloxifene treatment is associated with increased serum estradiol and decreased bone remodeling in healthy middle-aged men with low sex hormone levels. Journal of Bone and Mineral Research 2004; 19: 1518-1524. (Pubitemid 41094354)
100. Gao W, Reiser PJ, Coss CC et al. Selective androgen receptor modulator treatment improves muscle strength and body composition and prevents bone loss in orchidectomized rats. Endocrinology 2005; 146: 4887-4897. (Pubitemid 41446627)
101. Kearbey JD, Gao W, Narayanan R et al. Selective androgen receptor modulator (SARM) treatment prevents bone loss and reduces body fat in ovariectomized rats. Pharmaceutical Research 2007; 24: 328-335. (Pubitemid 46084804)